SPMED
Latest round
- Series A
Last raised
- Jul 2021
Total raised
- $5.2M
Investors
- 3
About SPMED
In 2016, the company was selected as the 7th Busan Metropolitan City Startup Support Project by the Busan Economic Promotion Agency. The next year, 2017, its head office went under expansion and relocation followed by an affiliation as a research institute from the Ministry of Science's ICT and Future Planning. In 2019, SPMED signed a contract with designated hospitals for drug genetic testing (Essem Hospital, Busan Sahmyook Hospital) and the company joined the Genome Industry Association in the same year. The company develops precision medicine based on genome, clinical information, living environment, and habit information.
Who invested in SPMED
3 investors across 1 round
See all investors in SPMED
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 21, 2021
Amount
$5.2M
Investors
Questions about SPMED
Who invested in SPMED?
SPMED has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SPMED raised?
SPMED has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SPMED last raise money?
SPMED's most recent round on record is a Series A, in Jul 2021.
What does SPMED do?
In 2016, the company was selected as the 7th Busan Metropolitan City Startup Support Project by the Busan Economic Promotion Agency.
Where is SPMED headquartered?
SPMED is headquartered in Busan, South Korea.
Which VCs invest in companies like SPMED?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at SPMED's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like SPMED? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.